In response to the HHS Centers for Medicare & Medicaid Services’ Request for Information on Medicare, Avalon Healthcare Solutions explained how improving the management of lab testing can play a critical role in achieving value-based care.
In its RFI response, Avalon offered CMS insight into the processes and innovation that will enhance the quality and affordability of lab tests for our nation’s seniors. Those recommendations include:
- Improving the prior authorization processes
- Making lab testing cost-effective
- Reducing medically unnecessary testing
- Implementing innovative coding and quality assessment techniques to incentivize value-based care
- Looking to lab results as evidence of accurate assessments on the severity of a patient’s health
In a letter to CMS, Bill Kerr, M.D., CEO of Avalon, said: “Lab testing is the gateway for the diagnosis and treatment of many conditions. Accordingly, managing lab testing will make sure that Medicare beneficiaries get the right test at the right time in the right location and for the right price.”
Read Avalon’s response to the CMS RFI on Medicare.
About Avalon Healthcare Solutions
Avalon Healthcare Solutions is the world’s first and only Lab Insights company, bringing together our proven Lab Benefit Management solutions, lab science expertise, digitized lab values, and proprietary analytics to help healthcare insurers proactively inform appropriate care, reduce costs, and improve clinical outcomes. Working with health plans across the country, the company covers more than 33 million lives and delivers 7-12% outpatient lab benefit savings. Avalon is pioneering a new era of value-driven care with its Lab Insights Platform that captures, digitizes, and analyzes lab results in real-time to provide actionable insights for earlier disease detection, ensuring appropriate treatment protocols, and driving down overall cost. For more information about Avalon, please visit www.avalonhcs.com.
Avalon Healthcare Solutions Media Contact:
EVP, Sales & Marketing